A novel STAT3 splice-site variant in a kindred with autosomal dominant hyper IgE syndrome
Abstract
Background: Dominant negative STAT3 loss-of-function is the most common genetic cause of hyper-IgE syndrome (HIES). Patients may present with a host of both immune and non-immune manifestations, including connective tissue abnormalities, recurrent infections, malignant predisposition, and biochemical evidence of elevated serum IgE or eosinophilia.
Aim: To describe a novel splice-site variant in STAT3 resulting in HIES.
Methods: Case report of two family members with HIES.
Results: A proband and his son presented with neonatal-onset pustular rash, recurrent skin and sinopulmonary infections and elevated serum IgE and were diagnosed with AD-HIES. They were identified to harbor a novel splice-site variant in the DNA-binding domain (DBD) of STAT3: c.1110-3C>G, predicted to result in defective splicing in exon 12. Interestingly, a number of other patients with AD-HIES have mutations affecting the same splice-site, suggesting this may be a hot-spot for mutagenesis.
Conclusion: Splice-site mutations in the DBD of STAT3 are increasingly identified as a cause of AD-HIES. Future work is required to delineate whether patients with splice-site mutations have unique clinical characteristics, supporting efforts for genotype-phenotype correlation in this disease.
Statement of Novelty: We present a novel splice-site mutation in the DNA-binding domain of STAT3 leading to autosomal dominant hyper-IgE syndrome.
Formats available
You can view the full content in the following formats:
REFERENCES
Alsalamah M., Vong L., Cimpean L., and Dadi H. 2019. Establishing reference ranges for lymphocyte proliferation responses to phytohemagglutinin in patients with T cell dysfunction. LymphoSign J. 6: 26–30.
Buckley R.H., Wray B.B., and Belmaker E.Z. 1972. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics, 49: 59–70.
Davis S.D., Schaller J., and Wedgwood R.J. 1966. Job’s Syndrome. Recurrent, ‘cold’, staphylococcal abscesses. Lancet Lond. Engl. 1: 1013–1015.
Grimbacher B., Holland S.M., Gallin J.I., Greenberg F., Hill S.C., Malech H.L., Miller J.A., O'Connell A.C., and Puck J.M. 1999. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N. Engl. J. Med. 340: 692–702.
Heimall J., Davis J., Shaw P.A., Hsu A.P., Gu W., Welch P., Holland S.M., and Freeman A.F. 2011. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin. Immunol. Orlando Fla. 139: 75–84.
Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schäffer A.A., Puck J.M., and Grimbacher B. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608–1619.
Hsu, A.P., Davis, J., Puck, J.M., Holland, S.M., and Freeman, A.F. 1993. STAT3 Hyper IgE Syndrome. In GeneReviews®. Edited by. M.P. Adam et al. University of Washington, Seattle.
Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., Metin A., and Karasuyama H. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature, 448: 1058–1062.
Merico D. 2016. Whole exome and genome sequencing for Mendelian immune disorders: from molecular diagnostics to new disease variant and gene discovery. LymphoSign J. 3: 135–158.
Renner E.D., Rylaarsdam S., Anover-Sombke S., Rack A.L., Reichenbach J., Carey J.C., Zhu Q., Jansson A.F., Barboza J., Schimke L.F., Leppert M.F., Getz M.M., Seger R.A., Hill H.R., Belohradsky B.H., Torgerson T.R., and Ochs H.D. 2008. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J. Allergy Clin. Immunol. 122: 181–187.
Sundin M., Tesi B., Böhme M.S., Bryceson Y.T., Pütsep K., Chiang S.C., Thunberg S., Winiarski J., and Wikström A-C. 2014. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology. J. Clin. Immunol. 34: 469–477.
Woellner C., Heropolitańska-Pliszka E., Yeganeh M., Moin M., Español T., Ehl S., Gennery A.R., Abinun M., Breborowicz A., Niehues T., Kilic S.S., Junker A., Turvey S.E., Plebani A., Sánchez B., Garty B-Z., Pignata C., Cancrini C., Litzman J., Sanal O., Baumann U., Bacchetta R., Hsu A.P., Davis J.N., Hammarström L., Davies E.G., Eren E., Arkwright P.D., Moilanen J.S., Viemann D., Khan S., Maródi L., Cant A.J., Freeman A.F., Puck J.M., Holland S.M., and Grimbacher B. 2010. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J. Allergy Clin. Immunol. 125: 424–432.e8.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 10 • Number 1 • March 2023
Pages: 15 - 19
History
Received: 27 February 2023
Accepted: 17 March 2023
Accepted manuscript online: 17 March 2023
Version of record online: 18 April 2023
Copyright
© 2023.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
OriScott, MarinaSham, LauraAbrego Fuentes, MyraPereira, and Vy HDKim. 2023. A novel STAT3 splice-site variant in a kindred with autosomal dominant hyper IgE syndrome. LymphoSign Journal.
10(1): 15-19. https://doi.org/10.14785/lymphosign-2023-0002
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
